Montpellier - France – July 10th, 2023 – CILcare, a biotechnology company specialized in auditory sciences and research and development of new therapies for inner ear and associated diseases, is…
CILcare has achieved a novel milestone by starting patient recruitment in their DIAMANT trial, the first clinical study aiming to deepen knowledge of the link between diabetes and hearing pathologies:…
CILcare’s team is honored to have been awarded by the French-American Chamber of New England (FACCNE) in the Women in Business category. The French-American Business Awards took place during FACCNE's…
Sylvie PUCHEU, CILcare’s Chief Scientific Officer and Philippe NERIN, SATT AxLR’s President Montpellier - France – May 17th, 2023 – CILcare, a company specialized in the research and development of…
CILcare’s team is honored and delighted to be part of the nominees for Women in Business Award by the French-American Chamber of New England (FACCNE). In one night only, FACCNE…
Ototoxicity resulting in inner ear damage is a leading cause of acquired hearing loss worldwide. About a billion people are at risk of avoidable hearing loss, according to the World Health…
Join CILcare and our partner CBSET at the Safety Pharmacology Society Northeast Regional Meeting, April 28, from 8:00 AM to 4:00 PM, at Takeda Cambridge, 125 Binney Street, Cambridge, Massachusetts. Lise Byelyayeva,…
Susanna Malmström, PhD, Alliances Director, will be in Marrakech on April 28-30, 2023 at the Third International Symposium of the International Society for Inner Ear Therapeutics. Key opinion leaders and…
Montpellier, France, March 13 2023 – CILcare, a company specialized in the R&D of novel therapies for hearing disorders, has the immense pleasure of welcoming four renown researchers in the…
CILcare's team will be in Orlando, FL, to take part in ARO's Midwinter Meeting on February 11-15, 2023. The Association for Research in Otolaryngology (ARO) is an international hearing and…
